Literature DB >> 11098851

Inhibition of repair of X-ray-induced DNA double-strand breaks in human lymphocytes exposed to sodium butyrate.

L Stoilov1, F Darroudi, R Meschini, G van der Schans, L H Mullenders, A T Natarajan.   

Abstract

PURPOSE: Sodium butyrate is known to inhibit histone deacetylase enzymes and to enhance the frequencies of X-ray-induced dicentrics and rings in human lymphocytes. In this study an investigation was made of the mechanisms underlying this enhancement by assessing the effect of sodium butyrate on the extent of X-ray-induced DNA damage and its repair in human peripheral blood lymphocytes. METHODS AND MATERIALS: Unstimulated G0 lymphocytes were pretreated for 24h with sodium butyrate at a final concentration of 5 mM, irradiated with different doses of X-rays and then analysed for different endpoints either immediately or after different repair periods. The frequencies of DNA strand breaks were determined biochemically using nucleoid sedimentation, alkaline elution and immunochemical analysis as well as cytogenetically using the premature chromosome condensation (PCC) technique.
RESULTS: The results show that sodium butyrate pretreatment does not lead to a significant increase of DNA double- or single-strand breaks nor to an increase of alkali labile base damage in G0 lymphocytes. Moreover, sodium butyrate treatment had no effect on the initial frequency of chromosome breaks. However, PCC analysis clearly showed that the presence of sodium butyrate post-irradiation severely inhibited DNA double-strand break (DSB) repair, which most likely accounts for the increase in X-ray-induced chromosome aberrations.
CONCLUSIONS: Sodium butyrate treatment leading to changes in histone acetylation and increased accessibility of chromatin had no effect on the initial levels of X-ray-induced DNA damage. However, sodium butyrate may affect either the chromatin configuration or the enzymatic activities that play a key role in the repair of DSB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11098851     DOI: 10.1080/09553000050176243

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  8 in total

1.  Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis.

Authors:  Hidemitsu Nakagawa; Yoshihiro Yui; Satoru Sasagawa; Kazuyuki Itoh
Journal:  J Neurooncol       Date:  2018-04-06       Impact factor: 4.130

2.  Site-specific Acetylation of Histone H3 Decreases Polymerase β Activity on Nucleosome Core Particles in Vitro.

Authors:  Yesenia Rodriguez; John M Hinz; Marian F Laughery; John J Wyrick; Michael J Smerdon
Journal:  J Biol Chem       Date:  2016-03-31       Impact factor: 5.157

3.  Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells.

Authors:  M Goh; F Chen; M T Paulsen; A M Yeager; E S Dyer; M Ljungman
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

4.  Radioprotective effects of valproic acid, a histone deacetylase inhibitor, in the rat brain.

Authors:  Yong Zhou; Junjie Niu; Shupeng Li; Huaying Hou; Ying Xu; Wei Zhang; Yuhua Jiang
Journal:  Biomed Rep       Date:  2014-10-01

Review 5.  Grand rounds at the National Institutes of Health: HDAC inhibitors as radiation modifiers, from bench to clinic.

Authors:  Jacob E Shabason; Philip J Tofilon; Kevin Camphausen
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

6.  Targeting the epigenome: effects of epigenetic treatment strategies on genomic stability in healthy human cells.

Authors:  Jan C Purrucker; Ulrich Mahlknecht
Journal:  Clin Epigenetics       Date:  2010-07-27       Impact factor: 6.551

7.  Processing of DNA double strand breaks by alternative non-homologous end-joining in hyperacetylated chromatin.

Authors:  Vasilissa Manova; Satyendra K Singh; George Iliakis
Journal:  Genome Integr       Date:  2012-08-22

8.  Acetylation regulates WRN catalytic activities and affects base excision DNA repair.

Authors:  Meltem Muftuoglu; Rika Kusumoto; Elzbieta Speina; Gad Beck; Wen-Hsing Cheng; Vilhelm A Bohr
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.